Long COVID-19 and Insulin Autoimmune Syndrome: A Case Report.
Clin Ther
; 45(9): e187-e192, 2023 Sep.
Article
em En
| MEDLINE
| ID: mdl-37524570
ABSTRACT
PURPOSE:
To describe a case report of a patient with symptoms associated with metabolic alterations 1 month after having COVID-19.METHODS:
Laboratory tests, clinical evaluations, and body composition assessments were performed by specialists.FINDINGS:
The patient presented excessive sweating, hot flashes, dizziness, blurred vision, and seizure. Laboratory tests indicated low glucose levels after convulsions (50, 42.7, and 55 mg/dL), high insulin levels (basal, 638 µIU/mL; 2-hour, >1000 µU/mL), and positivity for anti-insulin antibodies. The patient was diagnosed with insulin autoimmune syndrome. Treatment with azathioprine and nutritional recommendations improved remission. IMPLICATIONS SARS-CoV-2 infection or vaccination might induce insulin tolerance failure.
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Guideline
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article